PRIMAGEN
DEAD

Serial Number

78242016

Owner

PrimaGen Holding B. V.

Attorney

Michael B. Lasky

Filing Date

Apr 25, 2003

Add to watchlist:

No watchlists yet
View on USPTO

PRIMAGEN Trademark

Serial Number: 78242016 • Registration: 3411657

PRIMAGEN is a trademark filed by PrimaGen Holding B. V. on April 25, 2003. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

PrimaGen Holding B. V. (4 trademarks)

Meibergdreef 59
1105 BA Amsterdam , NL

Entity Type: 10

Trademark Details

Filing Date

April 25, 2003

Registration Date

April 15, 2008

Published for Opposition

January 29, 2008

Cancellation Date

November 21, 2014

Goods & Services

molecular diagnostic kits comprised of medical and diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology used to generate a clinical or scientific result by the amplification and/or detection of DNA or RNA sequences in tissues, body fluids and/or cells of human or animal origin, specifically in the field of HIV and other virus detection, mitochondrial function and/or toxicity, and for tumor marker detection

Medical and veterinary diagnostic apparatus and instruments to be used with molecular diagnostic kits used to generate a clinical or scientific result by the amplification and/or detection of DNA or RNA sequences in tissues, body fluids and/or cells of human or animal origin, specifically in the field of HIV and other virusdetection, mitochondrial function and/or toxicity, and for tumor marker detection

Scientific, medical and veterinary research services utilizing medical and diagnostic reagents for in vitro use in the fields of biochemistry, clinical chemistry and microbiology for generating clinical and scientific result by the amplification and/or detection of DNA or RNA sequences in tissues, body fluids and/or cells of human or animal origin, specifically in the field of HIV and other virus detection, mitochondrial function and/or toxicity, and for tumor marker detection

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 21, 2014 C8..
REGISTERED-PRINCIPAL REGISTER
Apr 15, 2008 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 4, 2008 TCCA
PUBLISHED FOR OPPOSITION
Jan 29, 2008 PUBO
NOTICE OF PUBLICATION
Jan 9, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 22, 2007 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2007 CNSA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Dec 19, 2007 AMPX
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2007 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 19, 2007 ERSI
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2007 TROA
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 20, 2007 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 20, 2007 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 20, 2007 CNSI
ASSIGNED TO EXAMINER
Jun 19, 2007 DOCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 16, 2006 RCSC
ASSIGNED TO LIE
Dec 16, 2006 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 24, 2006 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 28, 2005 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 10, 2005 RCSC
LETTER OF SUSPENSION MAILED
Jun 25, 2004 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2004 CRFA
PAPER RECEIVED
Mar 26, 2004 MAIL
NON-FINAL ACTION E-MAILED
Sep 28, 2003 GNRT
ASSIGNED TO EXAMINER
Sep 28, 2003 DOCK